MARKET WIRE NEWS
  1. Home
  2. Stock
  3. TRVI
  4. News
TRVI
Quote
Short
News
Articles
Message Board

Trevi Therapeutics Inc. (NASDAQ : TRVI ) News

Trevi Therapeutics Inc. (NASDAQ: TRVI) News Releases

TRVI News Releases
TRVI : NASDAQ
GlobeNewswire
Trevi Therapeutics Announces Completion of End-of-Phase 2 Meeting with the FDA, Gaining Alignment for Its Development Program for Idiopathic Pulmonary Fibrosis-Related Chronic Cough
TRVI : NASDAQ
GlobeNewswire
Trevi Therapeutics to Participate in Upcoming March Conferences
TRVI : NASDAQ
GlobeNewswire
Trevi Therapeutics to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
TRVI : NASDAQ
PR Newswire
Trevi Therapeutics Announces Publication of Data from the Phase 2b IPF Chronic Cough Trial of nalbuphine ER in the Journal of the American Medical Association (JAMA)
TRVI : NASDAQ
PR Newswire
Trevi Therapeutics Provides Strategic Updates Ahead of Annual LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference
TRVI : NASDAQ
SeekingAlpha
Trevi Therapeutics appoints new CFO
TRVI : NASDAQ
PR Newswire
Trevi Therapeutics Announces Appointment of David Hastings as Chief Financial Officer
TRVI : NASDAQ
SeekingAlpha
Trevi Therapeutics: "Buy" Rating For Haduvio Treating Chronic Cough In IPF And Beyond
TRVI : NASDAQ
SeekingAlpha
Trevi Therapeutics edges higher amid takeover speculation
TRVI : NASDAQ
SeekingAlpha
Trevi Therapeutics: Big Cough Data, Bigger Execution Risk

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.